Skip to content

Guided Bone Regeneration Combined With PRGF for Atrophic Edentulous Maxilla

Guided Bone Regeneration Combined With Plasma Rich in Growth Factors for Vertical and Horizontal Augmentation of the Atrophic Edentulous Maxilla: A Prospective Clinical Case Series With One-Year Follow-up

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07654218
Acronym
GBR-PRGF-Maxil
Enrollment
11
Registered
2026-06-17
Start date
2023-03-01
Completion date
2025-12-31
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Bone Loss, Alveolar Ridge Deficiency, Edentulous Maxilla, Atrophic, Jaw Atrophy

Brief summary

This prospective interventional clinical study evaluated guided bone regeneration combined with plasma rich in growth factors for vertical and horizontal augmentation of the atrophic edentulous maxilla. Participants with severe maxillary ridge atrophy requiring bone augmentation before implant-supported rehabilitation underwent guided bone regeneration using a composite graft of autogenous bone and anorganic bovine bone mineral combined with plasma rich in growth factors. Barrier membranes were stabilised with titanium pins, and lateral-window sinus floor elevation was performed when indicated. Implants were placed using a delayed protocol at re-entry after 6-9 months. Radiographic bone height and width were assessed by cone-beam computed tomography before surgery, immediately after surgery, at 6-9 months, and at 12 months. The study also recorded graft dimensional stability, implant placement, and surgical or postoperative complications.

Detailed description

Severe atrophy of the edentulous maxilla may limit fixed implant-supported rehabilitation because of insufficient residual alveolar ridge height and width. Guided bone regeneration is used to reconstruct deficient ridges before implant placement, while plasma rich in growth factors may provide an autologous fibrin matrix enriched with platelet-derived mediators. This prospective clinical study assessed a guided bone regeneration protocol combined with plasma rich in growth factors for reconstruction of the atrophic edentulous maxilla. Eligible participants presented with an edentulous atrophic maxilla requiring vertical and/or horizontal ridge augmentation before implant placement. The surgical protocol included guided bone regeneration using a composite graft of autogenous bone and anorganic bovine bone mineral in a 60:40 ratio, combined with plasma rich in growth factors prepared from autologous blood. The grafted area was covered with a barrier membrane stabilised with titanium pins. Titanium-reinforced PTFE membranes were used for defects requiring vertical space maintenance, while collagen membranes were used for horizontal augmentations. Lateral-window sinus floor elevation was performed simultaneously when indicated by posterior maxillary anatomy. Cone-beam computed tomography was obtained pre-surgically, immediately post-operatively, at 6-9 months, and at 12 months. Linear vertical and horizontal bone measurements were performed at three standardised maxillary reference sites: the lateral wall of the nasal cavity, the medial wall of the maxillary sinus, and the zygomatic apophysis. Bone gain was calculated in millimetres and as percentage change relative to the pre-surgical dimension. Graft resorption was calculated between the immediate post-operative and 12-month assessments. Implant placement and intraoperative or postoperative complications were also recorded.

Interventions

PROCEDUREGuided Bone Regeneration Combined With Plasma Rich in Growth Factors

Guided bone regeneration was performed for reconstruction of the atrophic edentulous maxilla. Autogenous bone harvested intra-orally was combined with anorganic bovine bone mineral in a 60:40 ratio and mixed with autologous plasma rich in growth factors. The grafted area was covered with a barrier membrane stabilised with titanium pins. Titanium-reinforced PTFE membranes were used for defects requiring vertical space maintenance, while collagen membranes were used for horizontal augmentations. Lateral-window sinus floor elevation was performed simultaneously when indicated. Implants were placed using a delayed protocol at re-entry after 6-9 months.

Sponsors

Universidade do Porto
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

All participants were assigned to a single intervention group and underwent guided bone regeneration combined with plasma rich in growth factors for vertical and/or horizontal augmentation of the atrophic edentulous maxilla. Simultaneous lateral-window sinus floor elevation was performed when clinically indicated by posterior maxillary anatomy. No comparator or control group was included.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Fully edentulous maxilla requiring implant-supported fixed oral rehabilitation * Atrophic maxillary alveolar ridge requiring vertical and/or horizontal bone augmentation before implant placement * Residual alveolar ridge width below 6 mm and/or residual bone height below 10 mm, as assessed by cone-beam computed tomography * ASA physical status I or II * Clinical indication for guided bone regeneration, with or without simultaneous maxillary sinus floor elevation * Adequate oral hygiene and willingness to comply with postoperative instructions and follow-up visits * Written informed consent provided.

Exclusion criteria

* ASA physical status III or higher * Uncontrolled systemic disease contraindicating oral surgery or bone regenerative procedures * Uncontrolled diabetes mellitus or other systemic condition expected to impair wound healing or bone regeneration * History of radiotherapy to the head and neck region * Current or previous intravenous antiresorptive or antiangiogenic therapy associated with risk of medication-related osteonecrosis of the jaw * Active oral infection at the surgical site * Untreated periodontal disease or poor oral hygiene incompatible with regenerative surgery * Heavy smoking or unwillingness to comply with perioperative smoking restrictions * Pregnancy or breastfeeding * Inability to understand the study procedures or provide informed consent * Inability or unwillingness to attend scheduled follow-up visits * Any medical, anatomical, or behavioural condition judged by the investigator to interfere with surgery, healing, follow-up, or interpretation of outcomes

Design outcomes

Primary

MeasureTime frameDescription
Change in Vertical and Horizontal Maxillary Bone DimensionsPre-surgery, immediately post-operative, 6-9 months, and 12 monthsVertical and horizontal bone dimensions were measured using standardized cone-beam computed tomography at three maxillary reference sites: the lateral wall of the nasal cavity, the medial wall of the maxillary sinus, and the zygomatic apophysis. Bone gain was calculated in millimeters and as percentage change relative to the pre-surgical dimension.

Secondary

MeasureTime frameDescription
Graft ResorptionImmediately post-operative to 12 monthsGraft resorption was calculated as the percentage change in vertical and horizontal bone dimensions between the immediate post-operative CBCT and the 12-month CBCT assessment.
Number of Dental Implants Placed6-9 months after augmentationNumber of dental implants placed during delayed implant placement at re-entry following guided bone regeneration.
Incidence of Surgical and Postoperative ComplicationsFrom augmentation surgery to 12 monthsIntraoperative and postoperative complications were recorded, including infection, graft loss, membrane-related complications, and other adverse events. Complications were classified according to severity and whether they affected graft integrity.

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026